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Abstract
Cells are constantly generating reactive oxygen species (ROS) during aerobic metabolism. As a
consequence, each cell is equipped with an extensive antioxidant defence system to combat
excessive production of ROS. Oxidative stress occurs in cells when the generation of ROS
overwhelms the cell's natural antioxidant defences. There is a growing consensus that oxidative
stress and the redox state of a cell plays a pivotal role in regulating apoptosis, a tightly controlled
form of cell death in which a cell partakes in its own demise. More recently, a role for reactive
nitrogen species (RNI) as both positive and negative regulators of cell death has been established.
This review describes the major sources of ROS and RNI in a cell, the control of cell death by these
species and the role of antioxidants as regulators of oxidative stress and apoptosis. Finally, the
various methods that can be employed in establishing a role for both ROS and RNI in apoptosis will
be discussed with particular emphasis on their intracellular detection.
Author Keywords: Apoptosis; Reactive oxygen species; Nitric oxide; Oxidative stress; Antioxidants
Abbreviations: ROS, Reactive oxygen species; O2.−, superoxide anion; .OH, hydroxyl radical; H2O2,
hydrogen peroxide; ER, endoplasmic reticulum; RNI, reactive nitrogen intermediates; NO, nitric
oxide; NOS, nitric oxide synthase; ONOO−, peroxynitrite; NAC, N-acetylcysteine; ETC, electron
transport chain; TNFα, tumour necrosis factor alpha; TNFR1, TNF receptor 1; SOD, superoxide
dismutase; NGF, nerve growth factor; IL1R, interleukin 1 receptor; TCR, T cell receptor; IL1β,
interleukin 1β; cGMP, cyclic guanosine monophosphate; RSNO, nitrosothiol; CAD, caspase-activated
DNAse; ICAD, inhibitor of caspase-activated DNAse; DTT, dithiothreitol; Ttg, tissue transglutamase;
PTP, permeability transition pore; Gpx, glutathione peroxidase; GSH, glutathione; DCFH-DA, 2′-7′dichlorodihydrofluorescein diacetate; DCF, 2′-7′-dichlorofluorescein; DAF2-DA, 4,5-di
aminofluorescein; L-NAME, NG-nitro-L-arginine methyl ester; L-NMMA, NG-methyl-L-arginine; 7-NI,
7-nitroindazole; L-NIO, N5-(1-iminoethyl)-L-ornithine; L-NIL, N5-(1-iminoethyl)-L-lysine; DPI,
diphenylene iodonium; DDC, diethyldithiocarbamate; GST, glutathione-S-transferase
1. Introduction
Reactive oxygen species (ROS) are constantly generated under normal conditions as a consequence
of aerobic metabolism. ROS include free radicals such as the superoxide anion (O2.−), hydroxyl
radicals (.OH) and the nonradical hydrogen peroxide (H2O2). They are particularly transient species
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due to their high chemical reactivity and can react with DNA, proteins, carbohydrates and lipids in a
destructive manner. The cell is endowed with an extensive antioxidant defence system to combat
ROS, either directly by interception or indirectly through reversal of oxidative damage. When ROS
overcome the defence systems of the cell and redox homeostasis is altered, the result is oxidative
stress.
Oxidative stress is implicated in the pathogenesis of several diseases including AIDS, Huntington's,
Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease and retinal degenerative
disorders. Evidently, the brain is particularly vulnerable. This is not surprising as the central nervous
system is highly aerobic and thus extremely susceptible to oxidative stress. Additionally, the
antioxidant defences of the brain are relatively low having almost no catalase and very low levels of
glutathione (Slivka and Slivka).
The mitochondria are a major site of generation of free radicals. Under physiological conditions,
electrons carried by the electron transport chain can leak out of the pathway and pass directly to
oxygen, generating O2.−. Other sources of O2.− include enzymes such as cytochrome P450 in the
endoplasmic reticulum (ER), lipoxygenases, cyclooxgenases, xanthine oxidase and NADPH oxidase.
The dismutation of O2.− by superoxide dismutase (SOD) results in the generation of H2O2, which can
then react with Fe2+ to form hydroxyl radicals via the Fenton reaction:
Fe2+ + H2O2 → Fe3+ + .OH + −OH
Hydroxyl radicals can also be generated via the metal catalysed Haber–Weiss reaction:
O2.− + H2O2 → O2 + .OH + −OH
Reactive nitrogen intermediates (RNI) are now also recognised as important radicals. Nitric oxide
(NO) is formed endogenously from the oxidation of L -arginine to L -citrulline by a family of NADPHdependent enzymes, the NO synthases. NO exists in different chemical forms (NO−, NO. and NO+)
and thus has a wide-ranging degree of chemical reactivity and functions in a variety of different
biological roles (Stamler et al., 1992). These include regulation of the cardiovascular system, smooth
muscle relaxation, neurotransmission, coagulation and immune regulation. Despite these beneficial
functions, the molecule has a pivotal role in cell death having the ability to both induce and protect
against apoptosis as well as driving an apoptotic response into a necrotic one. NO can also combine
with O2.− to form peroxynitrite (ONOO−), which shares some of NO's properties in that it too can
diffuse freely intra- and intercellularly and also acts as a powerful oxidant.
It is now well established that the generation or addition of ROS or RNI can cause cell death either by
apoptosis or necrosis, two distinct cell death pathways. Necrosis occurs usually in response to severe
trauma/injury to the cell and is characterised morphologically by cytoplasmic and mitochondrial
swelling, plasma membrane rupturing and release of the cellular contents into the extracellular
space. Generation of an inflammatory response ensues, which can cause further injury or even
death to neighbouring cells.
Apoptosis, by contrast, is a tightly regulated form of cell death in which a cell effectively partakes in
its own demise. The execution of the death programme is characterised by morphological and
biochemical changes. These include mitochondrial depolarisation and alterations in phospholipid
asymmetry, chromatin condensation, nuclear fragmentation, membrane blebbing, cell shrinkage and
2
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the formation of membrane bound vesicles termed apoptotic bodies (Kerr et al., 1972). Many of the
morphological changes associated with apoptosis are orchestrated by activation of a cascade of
proteases termed caspases (Cohen and Porter). The caspases are a family of cysteine proteases
comprising at least 14 members, all of which contain an active site thiol group necessary for activity
(Thornberry and Lazebnik, 1998). This thiol group renders them particularly susceptible to redox
modification by S-nitrosylation or oxidation. Such modifications result in the inhibition of their
catalytic activities.
A role for oxidative stress in the induction of apoptosis is provided by studies where the addition of
low levels of ROS induce apoptosis and the observation that various antioxidants such as Nacetylcysteine (NAC) can inhibit cell death (Lennon and McGowan). Additionally, ROS generation has
been reported to occur in TNF- and Fas-mediated apoptosis (Wolfe and Suzuki) as well as following
treatment of cells with various agents including ultraviolet irradiation and chemotherapeutic drugs
(Zamzami and Gorman). ROS and RNI are especially difficult to measure because of their very short
half-lives. Early studies on oxidative stress and apoptosis were hampered by the lack of specific and
sensitive detection methods with methods often restricted to the use of nonspecific probes. There
now exists a wide range of techniques for detecting ROS and RNI in cells. While antioxidants and
scavengers are effective tools for implicating ROS and RNI in apoptosis, a variety of probes permit
the detection of ROS and RNI production both in living cells and in cell lysates. Specific inhibitors can
be used to delineate the pathway at the source of ROS and RNI production. Here we will review the
regulation of ROS and RNI, the major sources of oxidative stress, the role of natural antioxidants in
controlling oxidative stress and the most commonly used techniques in the study of oxidative stress
in apoptosis.
2. Sources of ROS and RNI
2.1. Subcellular localisation of ROS/RNI production
Both ROS and RNI can be generated at many different organelles in response to various stimuli.
Major sources of ROS production include the mitochondrion, endoplasmic reticulum, plasma
membrane and cytosol, while RNIs are usually formed in the cytosol or at the mitochondrion (Fig. 1).
The mitochondrion is the organelle in eukaryotes responsible for aerobic respiration and it is the
most common source of ROS during apoptosis. In normal resting cells, 1–2% of electrons carried by
the mitochondrial electron transport chain (ETC) leak from this pathway and form the superoxide
free radical. Complex I, NADH–ubiquinone oxidoreductase and Complex III, ubiquinol–cytochrome c
oxidoreductase are the two sites where superoxide is produced (Beyer, 1992). O2.− generated by the
cycling of ubiquinol in the inner mitochondrial membrane, is produced primarily in the mitochondrial
matrix (Raha et al., 2000). High concentrations of the enzyme Mn-SOD in the mitochondrial matrix
ensure that this basal level of superoxide production is neutralised before it can cause damage to
the cell (Fig. 2).
Another oxidase gaining prominence in studies of apoptosis is NADPH oxidase, found at the plasma
membrane of phagocytes. Assembly and activation of this oxidase in response to a range of stimuli
occurs during immune responses. Evidence is mounting that a similar, NADPH-like oxidase is
expressed in a variety of cells throughout the body. Activation of this enzyme and subsequent
superoxide production is necessary for apoptosis in a variety of systems (Finkel and Tammariello).
3
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NO is synthesised endogenously by a family of enzymes called nitric oxide synthases (NOS). Three
major isoforms of this enzyme exist. While neuronal NOS (nNOS, NOS1) and endothelial NOS (eNOS,
NOS3) are Ca2+/calmodulin-dependent and constitutively expressed in a wide variety of cells,
inducible NOS (iNOS, NOS2) is Ca2+ independent and is expressed in cells of the immune system and
other cells in response to various stimuli (Nathan, 1997). The ability of some cells to regulate the
expression of iNOS allows them to produce large amounts of nitric oxide on demand. nNOS, eNOS
and iNOS are all present in the cytoplasm. The most recently discovered NOS, mitochondrial NOS
(mtNOS), is present exclusively in the mitochondrion (Bates; Bates and Tatoyan). Co-stimulation of
superoxide production and mtNOS can result in the formation of high concentrations of the highly
reactive and damaging peroxynitrite (Packer and Bringold). All NOS enzymes function as
homodimers. They generate nitric oxide (NO) by a two-step oxidation of the amino acid L -arginine
to citrulline and NO via the intermediate compound N-hydroxy-L-arginine (NHA). Activation of NOS
requires the binding of several co-factors, as reviewed by Groves and Wang (2000).
Many apoptotic signals generate ROS and RNI usually through the major sources outlined above.
Receptors, the immune system, intracellular calcium, intracellular proteins, metabolic pathways and
exogenously added chemicals are all capable of generating oxygen and nitrogen free radicals in a
cell.
2.2. Receptors
Tumour necrosis factor alpha (TNFα) is a pro-inflammatory cytokine that can bind to either TNF
receptor 1 (TNFR1) or TNFR2. Binding of TNFα to TNFR1 usually results in caspase activation and
apoptosis. It is well established that both ROS and RNI are generated by TNFα in many cell and tissue
types. While ROS generation is not believed to be important in TNF-mediated apoptosis, generation
of ROS by TNFα is critical for the phagocytic immune response against invading pathogens. (Woo et
al., 2000).
RNIs play a key role in both inducing and inhibiting TNFα-mediated apoptosis. Binder and colleagues
reported that NO generation was essential for TNFα-mediated apoptosis. In this study, binding of
TNFα to TNFR1 induced the expression of iNOS. Inhibition of iNOS activity abolished the cytotoxicity
of TNFα in MCF7 and other TNFα-susceptible cells (Binder et al., 1999). In a separate experiment,
HeLa cells transfected with eNOS were found to be resistant to TNFα-mediated apoptosis. The
authors found that TNFα activated eNOS through ceramide formation. Generation of NO in this
system was anti-apoptotic (Bulotta et al., 2001). These conflicting results highlight the dual effects
that RNI and indeed ROS can have in different cells.
The Fas receptor is another member of the TNFR superfamily. Its natural ligand is the Fas ligand.
Binding of Fas ligand to Fas receptor induces apoptosis by activating caspase 8 and caspase 3.
Detection of the rapid generation of ROS during Fas-mediated apoptosis has been reported and
NADPH oxidase activation has been identified as the primary source of ROS production (Suzuki et al.,
1998). The authors speculated that Fas activates a NADPH-like oxidase system in several cell types.
However, the generation of ROS does not appear to be essential for Fas-mediated apoptosis in
Jurkat T cells (Creagh and Cotter, 1999).
2.3. Growth factors
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Growth factors are generally required for cell survival and cell proliferation in mammalian cells. The
ability to proliferate independently of growth factors is one of the hallmarks of cancer. A
noncancerous cell will die by apoptosis in the absence of growth factors.
Nerve growth factor (NGF) is essential for the survival of most neurons. Tammariello et al. (2000)
studied ROS generation in NGF-deprived sympathetic neurons. They discovered that neuronal cells
express NADPH oxidase. NGF withdrawal was found to activate this enzyme, and NADPH oxidasedeficient neurons are resistant to apoptosis induced by NGF withdrawal. ROS generation following
growth factor withdrawal has also been documented for epidermal growth factor (EGF) (Lieberthal
et al., 1998).
Growth factors are involved in angiogenesis (the growth of new blood vessels). Two of these,
vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) are suspected of
activating eNOS through the protein kinase Akt. It is believed that the antiapoptotic effects of NO
may be required for VEGF-induced cell-cycle progression in vivo (Dimmeler et al., 1999).
2.4. Immune system
ROS/RNI generation plays an important role in the immune system. Phagocytes, including
macrophages and neutrophils, are capable of generating large quantities of RNI and ROS,
respectively. These free radicals are important for phagocytic anti-microbial and tumouricidal
immune responses. It has been reported that NO generation is necessary for macrophage-induced
apoptosis in at least some tumour cells (Cui et al., 1994).
Neutrophils have a short lifespan, usually about 24 h and ROSs appear to play an important role in
neutrophil survival (Kasahara et al., 1997). Activated neutrophils undergo spontaneous apoptosis
shortly after producing an ROS burst against invading pathogens. Research suggests that this
spontaneous apoptosis is mediated by endogenous ROS production (Lundqvist-Gustafsson and
Bengtsson, 1999). Survival of neutrophils incubated with antioxidants is greatly enhanced over 24 h
in culture (Oishi and Machida, 1997).
Cytokines are a diverse family of extracellular signaling proteins produced by cells. Growth factors,
such as NGF and EGF, are members of the cytokine superfamily. We have already discussed how
these cells mediate survival through altering the cellular redox state. Here we consider two cytokine
receptors present on immune cells, interleukin 1 receptor (IL1R) and T cell receptor (TCR).
Unlike NGF and EGF, interleukin 1β (IL1β) and TCR are pro-apoptotic. Apoptosis in astrocytes
mediated by IL1β is associated with NO production. Inhibition of NOS can partially inhibit apoptosis
in this system (Ehrlich et al., 1999). Pancreatic islet beta cells, however, require binding of both IL1β
and IFNγ with their respective receptors to induce iNOS expression and NO generation (Dupraz et al.,
2000).
NOS also plays a role in TCR-mediated apoptotic death. In the thymus, stimulation of TCR results in
the deletion of CD4, CD8 double-positive thymocytes. Expression of iNOS and subsequent NO
generation is the primary pathway responsible for this process (Tai et al., 1997).
2.5. Metabolic pathways and ROS
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Metabolic pathways may also play a role in ROS/RNI generation. Certain endogenous and exogenous
compounds undergo enzymatic reactions yielding free radical species such as superoxide and nitric
oxide. Proline, an amino acid, is one such compound. p53-dependent initiation of apoptosis involves
up-regulation of proline oxidase activity. The reducing potential of proline oxidase is transferred to
the ETC through the mediator cytochrome c. This extra reducing potential in the ETC supports the
generation of ROS (Donald et al., 2001).
Arachidonic acid is a lipid precursor to leukotrienes and prostaglandins. Under certain conditions,
metabolism of arachidonic acid generates ROS (Cadenas et al., 1983). Arachidonic acid administered
to human retinoblastoma Y79 cells induces apoptosis and the antioxidant glutathione can rescue
these cells from apoptosis (Vento et al., 2000).
Many exogenously added chemicals induce ROS formation in cells and tissues. Some, such as MPTP
in dopaminergic neurons, can produce free radicals directly without the need for enzymes. Most,
however, require enzymatic reactions. Cytochrome P450 is a superfamily of enzymes responsible for
detoxifying exogenous compounds. Some isoforms such as CYP3A are notorious ROS producers.
Cyclosporin A, an immunosuppressant, is metabolised by CYP3A and produces large quantities of
toxic ROS (Nguyen et al., 1999).
3. Regulation of apoptosis by ROS
The redox status of a cell can have obscure and elaborate effects on apoptosis. While addition of
exogenous ROS is sufficient to trigger the apoptotic cascade, the executioners of apoptosis, for
instance the caspases, are extremely sensitive to redox alterations and require a reducing
environment in which to function. Perhaps one of the most potent regulators of apoptosis is NO,
having the unique ability to both induce and block cell death. Anti-apoptotic effects of NO are
associated with low levels (10 nm–1 μm) of exposure from the activation of endogenous NOS and
from the slow release of NO from NO. donors. In addition, inhibition of apoptosis by NO can switch
apoptotic cell death to necrosis in systems where NO may be acting below the point of no return. In
these systems, inactivation of the execution machinery is not sufficient to prevent cell death and
cells eventually die by necrosis. The outcome depends on several factors including cell type, the level
of stress, redox state, the chemical form of NO and the ability of the cell to scavenge and detoxify
ROS.
NO either delivered by NO donors or endogenously produced by NOS enzymes induces apoptosis
both in vivo (Nishikawa and Donovan) and in several cell types in vitro, such as neuronal cells (Wei et
al., 2000), macrophages (D'Acquisto et al., 2001), cardiac myocytes (Andreka et al., 2001),
endothelial cells (Shen et al., 1998), lymphocytes and thymocytes (Okuda and Zhou). The
mechanisms of NO-induced apoptosis are presently under intensive investigation and several
mechanisms underlying the effects of NO on apoptosis have now been elucidated. These include
activation of the death receptor Fas through upregulation of Fas ligand expression (Stassi et al.,
1997), generation of peroxynitrite (Lin et al., 1995), inhibition of mitochondrial ATP synthesis
(Almeida and Bolanos, 2001) and inactivation of several antioxidant enzymes (Asahi and Dobashi). In
addition, NO activation of guanylate cyclase and resultant increases in intracellular calcium through
cGMP-gated channels has also been demonstrated as a mechanism of NO-induced apoptosis in
retinal cells in vivo (Donovan et al., 2001) (Fig. 3).
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NO has been reported to have protective effects against apoptosis in a variety of cell types including
lymphocytes (Mannick; Mannick and Melino), hepatocytes (Li and Billiar, 1999), endothelial cells
(Dimmeler and Rossig), neurons (Estevez et al., 1998) and eosinophils (Hebestreit et al., 1998).
Several mechanisms have been proposed to elucidate the ability of NO to confer protection against
cell death. These can be divided into cGMP-dependent and cGMP-independent mechanisms.
3.1. cGMP dependent mechanisms
NO can stimulate cGMP production through the activation of soluble guanylyl cyclase. NO
dependent generation of intracellular cGMP has been shown to protect against apoptosis in
lymphocytes (Genaro et al., 1995), eosinophils (Beauvais et al., 1995), embryonic motor neurons
(Estevez et al., 1998), PC12 cells (Kim et al., 1999) and ovarian follicles (Chun et al., 1995). Exactly
how cGMP protects against apoptosis is at present unclear. In serum-deprived PC12 cells, it is
thought to involve the activation of protein kinase G and the inhibition of caspase activation through
the prevention of cytochrome c release (Kim et al., 1999). Recently, cGMP was found to suppress
TNFα and ActD-induced apoptosis in hepatocytes (Li et al., 2000). In this study, there was a marked
increase in activation of the serine/threonine kinase Akt, indicating a link between cGMP signalling
and the Akt pathway. Activation of Akt can promote cell survival through phosphorylation of the
pro-apoptotic protein Bad (Datta et al., 1997) and procaspase-9 (Cardone et al., 1998) and by
preventing cytochrome c release from mitochondria (Kennedy et al., 1999). However, inhibition of
Akt activation did not block the protective effect of cGMP in this study suggesting the activation of
other survival pathways by cGMP.
3.2. cGMP-independent mechanisms
cGMP-independent mechanisms of NO protection of cell death include inhibition of lipid
peroxidation (Rubbo et al., 1994) or peroxyl radical scavenging (Kotamraju et al., 2001), prevention
of Bcl-2 cleavage (Kim et al., 1998a) and cytochrome c release and the induction of protective
proteins such as Hsp70 and Bcl-2 (Kim and Suschek). In addition, many of the protective actions of
NO are mediated by S-nitrosylation of proteins. S-nitrosylation involves the transfer of a nitric group
to cysteine sulfhydryls, leading to the formation of a nitrosothiol (RSNO). While the movement and
activity of nitric oxide is often restricting due to its very short half-life, nitrosothiols in comparison
can be very stable compounds.
The caspases are a family of cysteine proteases that play a crucial role in apoptosis. Activation of
caspase-3, one of the key executioners of apoptosis, results in cleavage of ICAD (inhibitor of caspaseactivated DNAse) and translocation of CAD (caspase-activated DNAse) to the nucleus ultimately
resulting in DNA fragmentation. Caspase-3 activation is often considered as the point of no return in
apoptosis and, thus, inhibition of caspases might provide a mechanism to abort the apoptotic
cascade. Caspases contain a highly conserved cysteine residue within their active site and therefore
are a target for S-nitrosylation. Caspases are also susceptible to oxidative modification by reactive
oxygen species such as H2O2 and can be readily converted to disulfides and mixed disulfides under
conditions of oxidative stress (Fadeel and Shacter). Evidence in support of caspase inhibition via Snitrosylation initially came from a study carried out on purified caspases. This study demonstrated
reversible inhibition of seven members of the caspase family. Dithiothreitol (DTT), an agent that
removes the NO group bound to the thiol group on proteins, reversed inhibition by NO, thereby
indicating direct S-nitrosylation of the caspase catalytic cysteine residue by NO (Li et al., 1997a). NO
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inhibition of caspase activity has also been observed in a number of cells where NO donors were
employed to inhibit caspase activities (Kim and Mohr). Endogenous NO has also been shown to
inhibit caspase-3 like activity. In a study by Mannick et al. (1999), caspase-3 was found to be
nitrosylated intracellularly and denitrosylated on Fas/Fas ligand cross-linking. Recently pro-caspase-3
was found to be S-nitrosylated on its catalytic-site cysteine in vivo (Rossig et al., 1999). Finally, NO
has been reported to protect against Fas-induced liver injury by inhibiting caspase activity (Fiorucci
et al., 2001). This caspase inhibition is DTT reversible, suggesting that cysteine S-nitrosylation is the
underlying mechanism of caspase regulation by NO in this study.
In addition to S-nitrosylation of caspase-3, both caspase-1 and caspase-8 have also been reported to
be nitrosylated in cells. NO produced by the NO donor SNAP or iNOS is sufficient to prevent TNFinduced apoptosis in hepatocytes. Both caspase-8 and caspase-3 were found to be reversibly
inhibited and caspase-8 was found to be S-nitrosylated in this system (Kim et al., 2000). Caspase-1,
shown to be involved in both apoptosis and cytokine maturation, is also thought to be S-nitrosylated
with the demonstration of the reversal of NO-induced inhibition of caspase-1 by DTT in macrophages
(Kim et al., 1998b).
It is evident that NO is a potent inhibitor of caspase activity both in vitro and in vivo and that this
inhibition is largely due to S-nitrosylation of the catalytic site cysteine conserved in all caspases. This
discovery has significant implications for the regulation of apoptosis by NO. Under an oxidising
intracellular environment, the caspases are inactivated, and therefore the cell must maintain a
reducing environment in order for the execution phase of apoptosis to occur.
Evidence is accumulating that NO modulates the biological functions of many other intracellular
signalling proteins by S-nitrosylation. These include tissue transglutaminase (Ttg), (Melino et al.,
1997), the two cysteine-transcription factors NF kappa B (DelaTorre and DelaTorre), and AP-1
(Tabuchi et al., 1994), both implicated in the regulation of apoptosis, several ion channels (Broillet;
Eu and Hart) and the protease calpain (Michetti et al., 1995) (Fig. 3). In addition, NO has also been
reported to impair p53 function possibly through amino acid modifications such as S-nitrosylation
(Chazotte-Aubert et al., 2001).
Redox modulation has been recognised as an important mechanism of regulation for the NMDA
receptor. Excessive stimulation of the NMDA receptor-coupled ion channel and the subsequent
generation of free radical species is implicated as a mechanism for neurotoxicity in many
neurological diseases including Huntington's disease, Alzheimer's disease, stroke and AIDS dementia.
The cell death pathway that ensues can either be necrotic or apoptotic depending on the intensity of
the initial insult (Bonfoco et al., 1995). S-nitrosylation of the receptor inhibits excessive activity and
as a result is neuroprotective (Lipton et al., 1998). Recently, site-directed mutagenesis identified a
critical cysteine residue that was shown to react under physiological conditions with NO by Snitrosylation (Choi et al., 2000).
The anti-apoptotic activity of NO is now well established. Inhibition of caspases via S-nitrosylation is
probably the best-characterised mechanism of inhibition and explains the extensive protective effect
of NO. However, additional targets for S-nitrosylation containing critical cysteine residues are
increasingly being identified. The transfer of the NO group to a free SH group is now gaining
acceptance as a ubiquitous mode of regulation of protein function comparable to phosphorylation
during apoptotic cell death.
8
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3.3. NO and the mitochondrion
Exposure of cells to NO concentrations of greater than 1 μm can result in inhibition of apoptosis.
However, while apoptosis is inhibited, necrotic cell death ensues. This may be due to a drop in
cellular levels of ATP due to the failure of mitochondrial energy production and the greater
dependence on ATP by apoptosis compared to necrosis (Leist and Leist). NO disrupts mitochondrial
function by reversibly inactivating cytochrome c oxidase, the terminal electron acceptor in the
respiratory chain thus stimulating superoxide generation by the respiratory chain, production of
peroxynitrite and ATP depletion (Cleeter and Cassina). Complex I and complex II are also inactivated
by NO. It is thought that NO-induced complex I inhibition may result from S-nitrosylation of critical
thiols (Clementi et al., 1998) while complex II is inactivated in vivo by mechanisms resembling
ONOO−-induced oxidative stress (Cassina and Radi, 1996).
Another site of action of NO on the mitochondria is the permeability transition pore (PTP) (Balakirev
and Borutaite). There is now increasing evidence in support of redox regulation of cytochrome c
release during apoptosis (Kirkland and Franklin, 2001). The PTP plays an essential role in apoptosis;
once opened, cytochrome c is released, resulting in the formation of the apoptososme, activation of
caspase-9 and execution of apoptosis. Recently, inhibition of mitochondrial PTP opening was
identified as a novel site of action for NO signalling in apoptosis (Brookes et al., 2000). Inhibition of
PTP opening would result in less cytochrome c available to initiate apoptosis. This study suggests
that a fine balance exists between the pro- and anti-apoptotic properties of NO at the level of the
mitochondrion.
4. Antioxidant defence mechanisms
Both ROS and RNI can be generated as a result of normal metabolic processes or from toxic insult. It
is clear that they are key participants in injury caused to cells, being capable of oxidative damage to
all of the major classes of macromolecules, including proteins, lipids, carbohydrates and nucleic
acids. Under normal conditions, antioxidant systems minimize the adverse effects caused by ROS
(Fig. 1). However, when ROS overwhelm the biological defences of the cell, the result is oxidative
stress. The importance of the antioxidant defence system is emphasised by antioxidant enzyme
dysfunctions, which have been demonstrated to be associated with several neurodegenerative
disorders including Parkinson's disease, Alzheimer's disease, Huntington's disease and amyotrophic
lateral sclerosis (Sun and Mates).
4.1. Primary defence mechanisms
Antioxidants can be divided into primary or secondary defence mechanisms. Components of the
primary antioxidant defence function to prevent oxidative damage directly by intercepting ROS
before they can damage intracellular targets. It consists of superoxide dismutase (SOD), glutathione
peroxidase (Gpx), catalase and thirodoxin reductase. Four classes of SOD have been identified to
date. These are Mn-SOD, Cu,Zn-SOD, Ni-SOD and extracellular SOD. All four SOD enzymes destroy
the free radical superoxide by converting it to H2O2 as follows:
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H2O2 is one of the major ROS in the cell. While low levels result in apoptosis, high levels can lead to
necrosis or caspase-independent apoptosis (Hampton and Creagh). The primary defence
mechanisms against H2O2 are catalase (Michiels et al., 1994) and GPx through the glutathione (GSH)
redox cycle (Reed, 1990). Catalase is one of the most efficient enzymes known and cannot be
saturated by H2O2 at any concentration (Lledias et al., 1998). It is present only in the peroxisome
fraction whereas the GSH redox cycle exists in the cytosol and mitochondria. Catalase reacts with
H2O2 to form water and molecular oxygen:
Overexpression of catalase in cytosolic or mitochondrial compartments has been demonstrated to
protect cells against oxidative injury (Bai et al., 1999). In addition, catalase-overexpressing
thymocytes are resistant to apoptosis (Tome et al., 2001). These studies not only demonstrate the
cytotoxic effects of H2O2 but also emphasise the importance of catalase in antioxidant defence.
4.2. Glutathione and the GSH redox cycle
The GSH system is probably the most important cellular defence mechanism that exists in the cell.
The tripeptide GSH (γ-Glu-Cys-Gly), not only acts as an ROS scavenger but also functions in the
regulation of the intracellular redox state. The system consists of GSH, glutathione peroxidase and
glutathione reductase. Glutathione peroxidase catalyses the reduction of H2O2 and other
peroxidases and converts GSH to its oxidised disulfide form (GSSG) as outlined below.
GSSG is then reduced back to GSH by glutathione reductase. The ability of the cell to regenerate GSH
(either by reduction of GSSG or new synthesis of GSH) is an important factor in the efficiency of that
cell in managing oxidative stress. The rate-limiting step for GSH synthesis is catalysed by the enzyme
-γ-glutamyl-cysteine synthase. Inducers of this enzyme have been reported to prevent glutamate
toxicity (Murphy et al., 1991). In addition, -γ-glutamyl-cysteine synthase knockout mice embryos fail
to gastrolate and develop distal apoptosis (Shi et al., 2000).
Under normal conditions, more than 95% of the GSH in a cell is reduced and so the intracellular
environment is usually highly reducing. A depletion of intracellular GSH has been reported to occur
with the onset of apoptosis in a number of studies (Oda and Xu) and quite often is accompanied by a
concomitant increase in ROS (Carmody et al., 1999). However, depletion of GSH will lower the
reducing capacity of the cell and can therefore induce oxidative stress without the intervention of
ROS. Depletion of GSH levels has been shown to be sufficient to induce apoptosis in a number of cell
types and can also render cells more susceptible to apoptosis induced by subsequent stimuli
(Fernandes and Wullner). The drop in GSH levels was found to be due to an increased rate of GSH
efflux rather than an inhibition of synthesis or intracellular oxidation of the tripeptide. This has been
reported in a study carried out in Fas-induced apoptosis in Jurkat T lymphocytes (van den
Dobbelsteen et al., 1996). In this study, inhibitors of the GSH transporter prevented the efflux of
GSH, suggesting that the selective opening of a GSH-specific membrane channel is responsible. This
is further supported by a more recent study where two specific inhibitors of carrier-mediated GSH
extrusion were employed to decrease GSH efflux and apoptosis (Ghibelli et al., 1998).
4.3. Bcl-2 as an antioxidant
The proto-oncogene Bcl-2 was initially characterised for its unique ability to block cell death
triggered by a diverse array of agents. At least 15 Bcl-2 family members have now been identified, all
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possessing at least one of four conserved motifs known as Bcl-2 homology domains. The Bcl-2 family
consists of both pro-apoptotic members such as Bax, Bad, Bid and Bik and anti-apoptotic members
including Bcl-2, Bcl-xL, Bcl-w and Mcl-1.
The mechanism by which Bcl-2 protects against apoptosis remains somewhat elusive with many
novel functions for Bcl-2 suggested (Bornkamm and Marin). The majority of research on Bcl-2 and
inhibition of apoptosis focuses on its interaction with and regulation of mitochondrial function
particularly the mitochondrial permeability pore (Kluck; Yang; Susin and Susin). However, the
localisation of Bcl-2 to intracellular sites of oxygen free radical generation, including the cytoplasmic
face of the mitochondrial outer membrane, endoplasmic reticulum and nuclear membranes led
Hockenbery et al. (1993) to study possible antioxidant properties of Bcl-2. This study demonstrated
that Bcl-2 expression protects cells against oxidant stress and led to the suggestion that Bcl-2 is a
death repressor molecule functioning in an antioxidant pathway. Further evidence in support of this
suggestion came from the observation that Bcl-2 knockout mice expressed a phenotype consistent
with that of mice exposed to chronic oxidative stress (polycistic kidney disease and follicular
hypopigmentation) (Veis et al., 1993). These early studies lead to research into possible redox
aspects of Bcl-2.
A study carried out in two mouse lymphoma cell lines demonstrated that overexpression of Bcl-2
leads to an increase in intracellular GSH levels (Mirkovic et al., 1997). Conversely, down-regulation of
Bcl-2 expression is associated with depletion of cellular glutathione (McCullough et al., 2001). These
studies indicate that Bcl-2 may modulate apoptosis through an intermediary pathway such as GSH
metabolism. Further studies on the relationship between Bcl-2 and GSH demonstrated that Bcl-2
expression alters GSH compartmentalisation (Voehringer et al., 1998). Overexpression of Bcl-2 leads
to a relocalisation of GSH from the cytosol to the nucleus. It is possible then that Bcl-2 inhibits
apoptosis through modulation of intracellular glutathione levels and its redistribution to the nucleus.
Such alterations can, in turn, change nuclear redox potential, creating a highly reducing environment
within the cell. The transcription factors p53, AP-1 and NF-κB are sensitive to redox change primarily
as they bind DNA in a redox sensitive mechanism (Morel and Barouki, 1999). The changes in nuclear
redox potential might then alter DNA binding of these transcription factors. The transcriptional
changes observed by Voehringer et al. (2000) using DNA microarrays and cells with different levels of
Bcl-2 are thought to be caused by Bcl-2 mediated nuclear GSH changes. It is hypothesised, therefore,
that GSH acts via a Bcl-2-dependent mechanism as a transcriptional regulator by altering the nuclear
redox environment.
Clearly, there is considerable evidence in support of the hypothesis that Bcl-2 inhibits apoptosis
through an antioxidant effect. However, there is also evidence to suggest that Bcl-2 acts against
nonoxidative injury. This is supported by the ability of Bcl-2 to protect against apoptosis in systems
where ROS generation is considered to be negligible (Jacobson and Shimizu). These studies were
carried out in near-anaerobic conditions on the assumption that cells do not generate significant
levels of ROS under such conditions. Measurement of ROS were not carried out in these studies and
since then, Degli Esposti and McLennan (1998) have demonstrated that mitochondria and cells do
produce ROS in virtual anaerobics. Therefore, the apparent contradiction in the mechanism of Bcl-2
protection against apoptosis may be due, at least in part, to lack of crucial measurements of ROS.
These studies emphasise the importance of employing adequate detection methods when studying
ROS generation.
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5. Measuring ROS/RNI
ROS and RNI are short-lived species and usually have half-lives of less than a second. Bursts of ROS
and RNI generation in cell signalling are generally over after a few seconds or a few minutes. As a
result, detecting oxidative stress in apoptosis can be difficult without the right approach.
5.1. Antioxidants and scavengers
Antioxidants are powerful tools with which to demonstrate the involvement of ROS in apoptosis. As
we described earlier, the cell possesses numerous antioxidants to buffer the generation of
potentially damaging oxidising agents.
There are many artificial antioxidants that can mimic the effects of natural antioxidants in a cell. Zinc
chloride, N-acetyl-1-cysteine, 1,10-phenanthroline and pyrrolidine dithiocarbomate are wellestablished antioxidants. ROS-dependent apoptosis can be inhibited with these compounds
(Carmody; Friesen and Kirkland). Gorman et al. (1999) demonstrated that ROS production induces
hsp72 and hsp27 expression in HL60 cells during stress responses. Preincubation with the
antioxidants pyrrolidine dithiocarbomate and 1,10 phenanthroline actually augmented apoptosis.
The authors concluded that increases in ROS contributed to the increased expression of hsp72 and
hsp27 and protected against apoptosis (Gorman et al., 1999).
While ROS may be generated by many different enzymatic and nonenzymatic mechanisms in a cell,
RNI are almost always generated by NOS. Antioxidants are usually less effective in determining the
involvement of NO in apoptosis. This is emphasised by DTT, which has been employed to reverse Snitrosylation of caspases (Li et al., 1997a) but can also reverse peroxide-induced caspase inactivation
(Carmody and Cotter, 2000). It is important, therefore, to verify S-nitrosylation of proteins and hence
the involvement of NO in apoptosis using analytical methods such as mass spectrometry (Zech et al.,
1999). Scavengers such as PTIO can also be used to determine the involvement of NO in cell death (
Boullerne et al., 1999). However, general NOS inhibitors are usually far more effective.
While antioxidants and NO scavengers are useful tools in determining the involvement of ROS/RNI in
apoptosis, one must also consider the limitations of these chemicals. Primarily, changing the redox
state of a cell may profoundly affect cellular signaling pathways. Also, because many antioxidants
are analogues of biological substrates, they may directly interfere with cellular signaling pathways.
Often, one antioxidant may only partially affect apoptosis while another may alter the process
completely. It is prudent to use at least two structurally unrelated antioxidants when determining
the role of ROS in apoptosis.
5.2. ROS detection
There are many methods for measuring free radical production in cells. Chemiluminescence of
luminol (Suzuki; Dahlgren and Mellqvist) and lucigenin (Gyllenhammar, 1987), cytochrome c
reduction (Dahlgren and Karlsson, 1999), ferrous oxidation of xylenol orange (Nourooz-Zadeh, 1999)
and DCFH-DA (Carmody; Tammariello and Ottonello) have all been used successfully to detect ROS
generation. The most straightforward techniques use cell permeable fluorescent and
chemiluminescent probes. Flow cytometry or fluorimetry can be used for the detection of ROS with
fluorescent probes.
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2′-7′-Dichlorodihydrofluorescein diacetate (DCFH-DA) is one of the most widely used techniques for
directly measuring the redox state of a cell. This is a cell permeable, relatively nonfluorescent
molecule. It has many advantages over other techniques developed. It is very easy to use, extremely
sensitive to changes in the redox state of a cell, inexpensive and can be used to follow changes in
ROS over time. Activity of cellular esterases cleave DCFH-DA into 2′-7′-dichlorodihydrofluorescein
(DCFH2). Peroxidases, cytochrome c and Fe2+ can all oxidise DCFH2 to 2′-7′-dichlorofluorescein (DCF)
in the presence of hydrogen peroxide (Fig. 4A). Accumulation of DCF in cells may be measured by an
increase in fluorescence at 530 nm when the sample is excited at 485 nm. Fluorescence at 530 nm
can be measured using a flow cytometer and is assumed to be proportional to the concentration of
hydrogen peroxide in the cells (Bass and Royall) (Fig. 4B).
It is important to understand the limitations of using this probe. Although DCFH-DA is used to
measure the concentration of hydrogen peroxide in cells, superoxide and NO generation are also
capable of oxidising DCFH2 (Rao et al., 1992). The presence of SOD in the cytosol (Cu,Zn-SOD),
mitochondria (Mn-SOD) and extracellular space (Ec-SOD) all convert superoxide into hydrogen
peroxide, resulting in the accumulation of DCF in the cells. Inhibitors of SOD can be used to eliminate
this source of hydrogen peroxide production. DCFH2 may also be oxidised independently of
hydrogen peroxide. Nitric oxide reacts with superoxide producing peroxynitrite. DCFH2 can be
directly oxidised to DCF by peroxynitrite (Fig. 4a). Inhibitors of NOS should be used to prevent NO
mediated DCFH2 oxidation (Kooy et al., 1997).
DCF, the oxidised fluorescent product of DCFH2, is membrane permeable and can leak out of cells
over time. Detecting slow hydrogen peroxide production over time can be difficult (Ubezio and
Civoli, 1994). Various analogues have been developed that retain their fluorescent properties but are
charged at physiological pH, which allows them to accumulate in the cell even during slow hydrogen
peroxide production.
Some cell types have low esterase activity. This can have important implications for detecting ROS
because DCFH-DA needs to be hydrolysed to DCFH2 by cellular esterases. DCFH-DA cannot be
oxidised by hydrogen peroxide to give a fluorescent product. Brubacher and Bols (2001) have shown
that DCFH-DA underestimates ROS generation in rainbow trout macrophages. In contrast, both
DCFH2 and the cytochrome c reduction assay measure comparable amounts of ROS production. The
authors conclude that careful consideration must be given to the levels of esterase activity in cells
before using this probe. In cells with low esterase activity or where the esterases are sequestered in
inaccessible parts of the cell, using the deacetylated probe DCFH2 or some other assay is advised.
In a model system using xanthine oxidase to generate superoxide, DCFH2 was found to be
insensitive to a 17-fold change in superoxide production. In contrast, nanomolar concentrations of
cytochrome c caused an accumulation of the fluorescent DCF (Burkitt and Wardman, 2001). The
authors conclude that in apoptotic cells, accumulation of DCF is due to cytochrome c release and not
superoxide. This is an important observation but DCFH2 is believed to measure hydrogen peroxide
directly and not superoxide. It is not surprising that here fluorescence is not observed over a 17-fold
change in concentration of superoxide. Certainly, there is clear evidence that DCFH-DA is able to
assess accurately the redox state in most cell systems. However, care should be taken to validate the
experiments using other techniques such as antioxidants and inhibitors. Used carefully, this probe
can be a powerful tool for analysing ROS production in cells.
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Luminol-dependent chemiluminescence (luminol-dependent CL) (Allen and Loose, 1976) and
lucigenin-dependent chemiluminescence (lucigenin-dependent CL) (Minkenberg and Ferber, 1984)
are alternative, cell permeable methods for detecting ROS production. Luminol is not sensitive to
superoxide production (Faulkner and Fridovich, 1993) but may undergo a chemiluminescent
oxidation with hydrogen peroxide (Littauer and Caraceni) and peroxynitrite (Kooy et al., 1997).
Lucigenin is specific for superoxide production, and only luminesces weakly in the presence of
hydrogen peroxide (Gyllenhammar and Faulkner).
Recently, a variation of the luminol-dependent CL assay has been developed. The assay is based on
the oxidation of luminol by sodium hypochlorite (NaOCl). Hydrogen peroxide reacts with this
oxidised product, generating an excited molecule capable of luminescence. This assay is specific for
hydrogen peroxide, unlike luminol-dependent CL and can detect nanomolar concentrations of
hydrogen peroxide (Mueller and Mueller).
Luminol- and lucigenin-dependent CL possess many of the advantages of fluorescent probes such as
DCFH-DA. They are easy to use, sensitive, inexpensive and can measure ROS generation in intact
cells over time. They possess advantages over DCFH-DA in that they do not need to be cleaved by
esterases and can be used in systems with low esterase activity. Also, cytochrome c is not able to
catalyse chemiluminescent reactions and cannot interfere with ROS measurements during
apoptosis.
Controversy has surrounded lucigenin since it was suggested that redox cycling of lucigenin can lead
to extra superoxide production (Liochev and Liochev). Barbacanne et al. (2000) suggest that electron
donors such as NADH and NADPH yield large amounts of superoxide when incubated with lucigenin.
The authors found that in systems where very low levels of superoxide are produced, lucigenin must
be used at a concentration that causes extra superoxide generation. When measuring low levels of
superoxide, alternative methods of detection including DCFH-DA or cytochrome c reduction should
be used instead. Further studies, however, validate lucigenin-dependent CL as an assay for
superoxide production in most systems. Li et al. (1998) have shown that lucigenin produces
superoxide when used above a threshold concentration in vitro. The authors analysed superoxide
production in numerous enzymatic and cellular systems including mitochondrial and NADPH oxidase
generated superoxide. They demonstrated that lucigenin effectively detects low levels of superoxide
without causing additional superoxide production.
5.3. Nitric oxide detection
Like ROS detection, there exist a wide variety of techniques for detecting RNI in biological samples
including -3H-arginine metabolism (Bulotta et al., 2001), chemiluminescence of NO. reacting with
ozone (Misso et al., 2000), anion exchange HPLC (Marzinzig et al., 1997), fluorescent probes such as
4,5-di aminofluorescein (DAF2-DA) (Nakatsubo and Nakatsubo) and DCFH-DA (Kooy et al., 1997),
spin traps such as N-(dithiocarbanoyl)-N-methyl- -glucamine (MGD) (Venkataraman et al., 2000) and
the Griess reagent (Green and Archer). With the exception of DAF2-DA and MGD, all of the assays
above detect NO degradation products such as nitrites, nitrates and peroxynitrites.
When measuring the end products of NO metabolism, the Griess reaction is usually the preferred
assay. It is the most sensitive and has the largest linear range for routine analysis of nitric oxide
(Marzinzig et al., 1997). In the Griess reaction, nitrite reacts with sulfanalic acid and N-(1-naphthly)14
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ethylenediamine dihydrochloride in the presence of phosphoric acid and produces a coloured azo
dye, which can be measured colorimetrically at 548 nm. This value is proportional to the amount of
nitrite in the solution. The detection limit of the Griess reagent is between 100 nM and 1 μM (Tracey
et al., 1990).
An adaptation of this protocol by Schulz et al. (1999) is 500 times more sensitive than the traditional
Griess reaction and 7 times more sensitive than anion exchange HPLC. It can be used when great
sensitivity of detection is required, but is not necessary in the majority of cases of apoptosis.
One major drawback to the Griess reaction is that it is unable to detect changes in NO production in
cells over time. When measuring real time changes in NO production in cells, an alternative assay
such as DAF-2 DA is required. DAF-2 DA is cell permeable and reacts with the NO. free radical,
producing a highly fluorescent derivative. DAF-2 DA is excited at 492 nm and fluoresces at 515 nm.
Like DCFH-DA, esterase activity is required before the probe can be oxidised and fluoresces. A
negative control for DAF-2 DA is also available. It is called 4-aminofluorescein diacetate (4AF DA)
(Kojima et al., 1998).
DAF-2 DA fluorescence has been measured in a fluorimeter and also using confocal microscopy.
However, Broillet and colleagues have shown that the intense light produced in laser scan confocal
microscopes is capable of enhancing DAF-2 DA fluorescence in the presence of NO. Also, Ca2+
greatly enhances DAF-2 DA fluorescence in the presence of NO. Also Ca2+ greatly enhances DAF-2
DA fluorescence in the presence of NO. DAF-2 DA will fluoresce in organelles with high Ca2+
concentration including the mitochondria and endoplasmic reticulum even though these may not be
the original sources of NO production. Also, using DAF-2 DA in systems where intracellular Ca2+
increases may also produce misleading results of NO production. Because of these factors, confocal
microscopy measurements of DAF-2 DA fluorescence in cells is prone to numerous errors (Broillet et
al., 2001). Changes in intracellular Ca2+ occurs in several apoptotic systems (Lopez; Creagh and
Donovan). When measuring NO in such systems, it is necessary to confirm NO production using
another assay such as the Griess reaction (Rodriguez-Lopez et al., 2000) or specific NOS inhibitors
(Donovan et al., 2001).
5.4. Glutathione
The redox state of a cell can be altered without an increase in ROS or RNI generation. As discussed
earlier, this can occur due to a depletion of glutathione, the most important antioxidant defence
mechanism in the cell. Measuring glutathione levels in a cell, therefore, can often be valuable in
determining the overall redox state of the cell. Ortho-pthaldialdehyde (OPT) (Domenicotti et al.,
2000), 5,5-dithiobis(2-nitrobenzoic acid) (Li et al., 1997b) and monochlorobimane (Rice et al., 1986)
have all proved useful in determining the intracellular concentrations of glutathione.
Monochlorobimanes and bromobimanes are versatile, membrane permeable nonfluorescent probes
that bind irreversibly to sulfydryl groups yielding a fluorescent product (Kosower and Kosower,
1995). Fluorescence can be measured in a fluorimeter with excitation and emission maxima set at
395 and 480 nm, respectively, or using flow cytometry (Rice et al., 1986). The authors reported very
low reactivity of monochlorobimane with protein sulfydryl residues other than GSH. However, it is
advisable to determine the glutathione levels using a protein-free assay. OPT, another fluorescent
probe, can accurately assess total glutathione levels in protein precipitated cell lysates (Kaul et al.,
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1998). It is also possible to estimate the ratio of GSH/GSSG from experiments using
monochlorobimanes and OPT.
Depletion of intracellular glutathione levels can be achieved either using inhibitors of glutathione
synthesis or by metabolising intracellular glutathione. -buthionine-S,R-sulfoximine (BSO) is a cell
permeable, selective and irreversible inhibitor of the enzyme γ glutamyl-cysteine synthetase, the
first step in synthesising glutathione (Terradez et al., 1993). Glutathione-S-transferase (GST)
substrates can also be used to deplete glutathione levels in cells. Diethylmaleate, a GST substrate, is
conjugated to GSH by glutathione-S-transferase and subsequently eliminated from the cell (Saez et
al., 1985). A recent study that employed diethylmaleate successfully resulted in GSH depletion and
induced apoptosis in rat hepatocytes (Domenicotti et al., 2000).
5.5. Inhibitors of NOS
NO is synthesised by three major NOS isoforms; iNOS, eNOS and nNOS (Nathan, 1997). Inhibitors of
NOS activity are often effective in demonstrating the involvement of nitric oxide in apoptosis.
General inhibitors have a similar potency against the three NOS isoforms. Examples of general
inhibitors include NG-nitro-L-arginine methyl ester (L-NAME) (Rees et al., 1990) and NG-methyl-Larginine (L-NMMA) (Joly and Olken). Specific inhibitors display greater affinity for one or two NOS
isoforms. Examples of these include 7-nitroindazole (7-NI) (Bland and Moore), N5-(1-iminoethyl)-Lornithine (L-NIO) (Rees et al., 1990) and N5-(1-iminoethyl)-L-lysine (L-NIL) (Moore et al., 1994). The
majority of NOS inhibitors are derived from amino acids and usually do not affect other metabolic
pathways at the concentrations needed for NOS inhibition.
General NOS inhibitors can be used to determine whether the production of NO is directly involved
in apoptosis. Specific inhibitors of NOS can be used to characterise further the source of NO
generation. 7-NI and 3-bromo-7-NI are potent inhibitors of nNOS (Bland-Ward and Moore, 1995)
and have been effectively used to inhibit apoptosis (Williams et al., 1998).
Specific inhibitors of iNOS are also available. -NIL exhibits a 30-fold selectivity for iNOS over nNOS
(Moore et al., 1994). However, perhaps the most potent and specific inhibitor of iNOS is N-(3(aminomethyl)benzyl) acetomidine (1400W). 1400W irreversibly inhibits iNOS with a 5000-fold
greater selectivity than eNOS and 200-fold greater selectivity over iNOS. Although 1400W can be
toxic to cells, inhibition of iNOS usually occurs far below its threshold for cytotoxicity (Garvey et al.,
1997).
There have not been any specific eNOS inhibitors developed. However, a combination of general
inhibitors against NOS and specific inhibitors for nNOS and iNOS can elucidate the role of eNOS in
oxidative stress and apoptosis.
5.6. Inhibitors of ROI
Although antioxidants are more effective in determining the role of ROI in apoptosis, there are also
inhibitors of ROI production available. These can be very useful in determining the source of ROI
generation in oxidative stress, but care should be exercised when using them. Some inhibitors of ROI
production are nonspecific and/or toxic to the cells or tissues in which they are used.
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As we mentioned earlier, mitochondria are the primary source of ROI production in apoptosis. Two
sites on the ETC, NADH-ubiquinone oxidoreductase (complex I) and ubiquinol-cytochrome c
oxidoreductase (complex III) are capable of generating superoxide. Rotenone is an inhibitor of
electron transport in the ETC, binding to a site on complex I. It has been used as a specific inhibitor
of superoxide production by complex I. Myxothiazol inhibits electron transport at complex III and has
been used as a specific inhibitor of superoxide generation at complex III (Li et al., 1998) (Fig. 2).
Another important source of ROI in apoptosis is NADPH oxidase. NADPH oxidase activity can be
inhibited using diphenylene iodonium (DPI) (O and Tammariello). A drawback to using DPI is that it
also inhibits NOS activity (Stuehr et al., 1991).
Inhibition of SOD and catalase is sometimes desirable. SOD inhibitors include diethyldithiocarbamate
(DDC) (Liu and Jan, 2000) and triethylenetetramine (An and Hsie, 1993). Cyanide, a nonspecific
inhibitor, can also inhibit SOD activity. These only inhibit Cu,Zn-SOD and have no effect on Mn-SOD
activity (Iqbal and Whitney, 1991). Catalase may be inhibited using the specific aminotriazole or the
nonspecific inhibitor cyanide (Putnam et al., 2000). Finally, inhibition of cytochrome P450 enzyme
activity, a major source of ROI in chemically induced oxidative stress, is possible using SFK or 1aminobenzotriazole (Shiba and Shimamoto, 1999).
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FIGURE LEGENDS
Fig. 1. Intracellular sources of ROS and principle defence mechanisms. Major sources of ROS
production include the mitochondria, endoplasmic reticulum, plasma membrane and cytosol. The
mitochondria generate O2.− during respiration, which is converted to H2O2 by Mn-SOD. In the
cytosol, O2.− is converted to H2O2 by Cu,Zn-SOD. The two major defence systems against H2O2 are
the GSH redox cycle present in both the cytosol and mitochondria and catalase present only in the
peroxisome fraction. Other sources of O2.− include the enzymes xanthine oxidase in the cytosol,
NADPH oxidase in the membrane and cytochrome P450 in the ER. Bcl-2 can function as an
antioxidant in some apoptotic systems through inducing the relocalisation of GSH to the nucleus. NO
can be produced in the cytosol by nNOS, eNOS and iNOS or in the mitochondria by mtNOS.
Additionally, TNFα can induce NOS activation, resulting in the generation of nitric oxide. NO2 can
react with membrane lipids and can also cause mutations in DNA. In addition, ONOO− can induce
lipid peroxidation. Vitamin E (γ-tocopherol) is the main membrane antioxidant and is effective in
inhibiting peroxynitrite oxidation of lipids and can also detoxify NO2 (Cooney and Christen). For
more details, see text.

32

J Immunol Methods. 2002 Jul 1;265(1-2):49-72. Review.
PMID: 12072178
Fig. 2. Schematic diagram illustrating the major subunits of the electron transport chain (ETC) and
sites of O2.− production. Electrons enter the ETC at either complex I (NADH-ubiquinone
oxidoreductase) or complex II (succinate dehydrogenase) following the oxidation of NADH and
succinate, respectively. Ubiquinone is a lipid-soluble electron carrier and carries the electrons from
complex I and complex II to complex III (ubiquinol-cytochrome c oxidoreductase). Superoxide (O2.−)
can be produced at both complex I and complex III. It is believed that semiquinone formation at both
complex I and complex III results in the production of O2.−. The inhibitors rotenone and myxathiazol
inhibit electron transport at complex I and complex III of the ETC, respectively. These inhibitors can
be used to prevent increases in superoxide produced by the mitochondria.
Fig. 3. Schematic model of NO regulation of cell death. NO can regulate cell death through cGMPdependent and cGMP-independent mechanisms. Activation of GC by NO results in the production of
cGMP, which can regulate apoptosis through modulation of ion channels or activation of protein
kinases such as Akt. cGMP-independent mechanisms are largely mediated through S-nitrosylation
reactions. Proteins that have been reported to be S-nitrosylated include several members of the
caspase family, tissue transglutamase, the two cysteine-transcription factors NF kappa B and AP-1,
the G protein Ras, several ion channels including the NMDA receptor and complex 1 of the electron
transport chain.
Fig. 4. (A) Mechanism of action of DCFH-DA. DCFH-DA, a cell permeable, nonfluorescent precursor of
DCF can be used as an intracellular probe for oxidative stress. Intracellular esterases cleave DCFH-DA
at the two ester bonds, producing a relatively polar and cell membrane-impermeable product,
H2DCF. This nonfluorescent molecule accumulates intracellularly and subsequent oxidation by
hydrogen peroxide (or peroxynitrite) yields the highly fluorescent product DCF. The redox state of
the sample can be monitored by detecting the increase in fluorescence. Various inhibitors can be
used to elucidate the source of the oxidative stress. See text for more details. (B) Flow cytometric
detection of oxidative stress using DCFH-DA. DCFH-DA detects oxidative stress in DU145 cells by
treating with 40 μM hydrogen peroxide for 10 min and 1 μM anisomycin for 6 h. Hydrogen peroxide
is well known to induce oxidative stress in cells. Anisomycin is believed to activate the stress kinases
through the generation of ROS. Increased fluorescence in the FL-1 channel indicates increased levels
of oxidative stress.

33

J Immunol Methods. 2002 Jul 1;265(1-2):49-72. Review.
PMID: 12072178
Figure 1

34

J Immunol Methods. 2002 Jul 1;265(1-2):49-72. Review.
PMID: 12072178
Figure 2

35

J Immunol Methods. 2002 Jul 1;265(1-2):49-72. Review.
PMID: 12072178
Figure 3

36

J Immunol Methods. 2002 Jul 1;265(1-2):49-72. Review.
PMID: 12072178
Figure 4 A

Figure 4B

37

